GR1008168B - Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof - Google Patents
Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereofInfo
- Publication number
- GR1008168B GR1008168B GR20130100156A GR20130100156A GR1008168B GR 1008168 B GR1008168 B GR 1008168B GR 20130100156 A GR20130100156 A GR 20130100156A GR 20130100156 A GR20130100156 A GR 20130100156A GR 1008168 B GR1008168 B GR 1008168B
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- antibacterial agent
- parenteral formulation
- fluoroquinolone antibacterial
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to an aqueous pharmaceutical formulation of Moxifloxacin or a pharmaceutically acceptable salt thereof and propylene glycol to be used for the treatment of infections in humans or animals. The present invention also provides a method of preparation of such formulation.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20130100156A GR1008168B (en) | 2013-03-14 | 2013-03-14 | Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof |
EP14722987.6A EP2976063A1 (en) | 2013-03-14 | 2014-03-13 | Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof |
PCT/EP2014/000668 WO2014139677A1 (en) | 2013-03-14 | 2014-03-13 | Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20130100156A GR1008168B (en) | 2013-03-14 | 2013-03-14 | Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1008168B true GR1008168B (en) | 2014-04-08 |
Family
ID=50687438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20130100156A GR1008168B (en) | 2013-03-14 | 2013-03-14 | Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2976063A1 (en) |
GR (1) | GR1008168B (en) |
WO (1) | WO2014139677A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026110A1 (en) * | 1993-05-15 | 1994-11-24 | Abbott Laboratories | Stable quinolone and naphthyridine premix formulations |
JPH0782141A (en) * | 1993-09-17 | 1995-03-28 | Tanabe Seiyaku Co Ltd | Injection for animal |
US20070197548A1 (en) * | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone compositions |
US20090163484A1 (en) * | 2006-03-08 | 2009-06-25 | Bayer Animal Health Gmbh | Pharmaceuticals containing fluoroquinolones |
EP2078527A1 (en) * | 2006-10-12 | 2009-07-15 | Kyorin Pharmaceutical Co., Ltd. | Aqueous liquid preparation comprising gatifloxacin |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3906365A1 (en) | 1988-07-15 | 1990-01-18 | Bayer Ag | 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM |
DE19937116A1 (en) | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin saline formulation |
CN1384745A (en) | 1999-11-01 | 2002-12-11 | 爱尔康公司 | Pharmaceutical compositions containing fluoroquinolone antibiotic drug and xanthan gum |
US6872723B2 (en) * | 2002-01-28 | 2005-03-29 | Wyeth | Stabilized difloxacin injectable solution |
US20080033008A1 (en) * | 2006-08-07 | 2008-02-07 | Ward Keith W | Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
US20090118262A1 (en) * | 2007-11-01 | 2009-05-07 | Rohrs Brian R | Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery |
US20110319502A1 (en) * | 2010-06-25 | 2011-12-29 | Coffey Martin J | Compositions and Methods for Enhancing Reduction of Spore-Forming Microorganisms |
-
2013
- 2013-03-14 GR GR20130100156A patent/GR1008168B/en active IP Right Grant
-
2014
- 2014-03-13 WO PCT/EP2014/000668 patent/WO2014139677A1/en active Application Filing
- 2014-03-13 EP EP14722987.6A patent/EP2976063A1/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026110A1 (en) * | 1993-05-15 | 1994-11-24 | Abbott Laboratories | Stable quinolone and naphthyridine premix formulations |
JPH0782141A (en) * | 1993-09-17 | 1995-03-28 | Tanabe Seiyaku Co Ltd | Injection for animal |
US20070197548A1 (en) * | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone compositions |
US20090163484A1 (en) * | 2006-03-08 | 2009-06-25 | Bayer Animal Health Gmbh | Pharmaceuticals containing fluoroquinolones |
EP2078527A1 (en) * | 2006-10-12 | 2009-07-15 | Kyorin Pharmaceutical Co., Ltd. | Aqueous liquid preparation comprising gatifloxacin |
Also Published As
Publication number | Publication date |
---|---|
WO2014139677A1 (en) | 2014-09-18 |
EP2976063A1 (en) | 2016-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL257481B (en) | Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereof | |
HK1250714A1 (en) | Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with pi3 kinases, containing same as active ingredient | |
HK1232120A1 (en) | Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same | |
PH12015502013A1 (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
PH12015501957A1 (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
EP2987786A4 (en) | Amidopyridinol derivative or pharmaceutically acceptable salt thereof and pharmaceutical composition comprising same as active component | |
HK1208378A1 (en) | Pharmaceutical composition for the treatment of fungal infections | |
EA032271B9 (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
PT3103453T (en) | Medicinal composition comprising diamino heterocyclic carboxamide compound as active ingredient | |
EP3085369A4 (en) | Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain | |
GR1008186B (en) | Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof | |
GR1008168B (en) | Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof | |
EP3082766A4 (en) | Liquid formulation comprising montelukast or pharmaceutically acceptable salt thereof and method for preparing same | |
MX360040B (en) | Novel phenicol antibacterial agents. | |
PH12016502548A1 (en) | Antimicrobial compositions with effervescent agents | |
GR1008169B (en) | Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof | |
GR1008258B (en) | Ophthalmic formulation of fluoroquinolone antibacterial agent and method for preparation thereof | |
ZA201304316B (en) | Ophthalmic formulation of fluoroquinolone antibacterial agent and method for preparation thereof | |
UA91125U (en) | Antibacterial composition | |
EP3101014A4 (en) | Novel 2-phenylbenzofuran derivative or pharmaceutically acceptable salt thereof, production method for same and pharmaceutical composition for preventing or treating inflammatory disease comprising same as active ingredient | |
UA88315U (en) | Antibacterial composition | |
IN2013MU01983A (en) | ||
ZA201302189B (en) | Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20140515 |